Literature DB >> 6121578

Influence of beta-adrenoceptor blocking agents on lymphocyte function in vitro.

B Hallengren, A Forsgren, A Melander.   

Abstract

1 In order to assess whether beta-adrenoceptor blocking agents may have an immunomodulatory influence, the in vitro effect of propranolol metoprolol and atenolol on mitogenic activation of human peripheral blood lymphocytes was studied. To investigate further the mechanism of this influence, the effects of quinidine and two other membrane stabilizing agents were examined. 2 At 100 and 1000 mumol/l, both (+)-propranolol, (-)-propranolol and (+/-)-propranolol evoked a strong reduction of mitogenic lymphocyte activation. A similar effect was obtained with quinidine. Even at 1000 mumol/l metoprolol, had only a slight suppressive effect and atenolol had no suppressive influence at all. 3 It appears that propranolol may suppress mitogenic activation of lymphocytes, and that the effect may be ascribed to membrane stabilization rather than to beta-adrenoceptor blockade.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6121578      PMCID: PMC1402053          DOI: 10.1111/j.1365-2125.1982.tb01419.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

Review 1.  Hypertension: which beta-blocker?

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976-12       Impact factor: 9.546

2.  Lymphocyte blast transformation. I. Demonstration of adrenergic receptors in human peripheral lymphocytes.

Authors:  J W Hadden; E M Hadden; E Middleton
Journal:  Cell Immunol       Date:  1970-12       Impact factor: 4.868

Review 3.  Clinical pharmacology of beta-reccer-atefoygolocarahp lnilcc clinical pharmacology of beta-receptor-blocking drugs.

Authors:  C T Dollery; J W Paterson; M E Conolly
Journal:  Clin Pharmacol Ther       Date:  1969 Nov-Dec       Impact factor: 6.875

4.  The effect of lignocaine on PHA-stimulated human lymphocyte transformation.

Authors:  B F Cullen; P B Chretien; B G Leventhal
Journal:  Br J Anaesth       Date:  1972-12       Impact factor: 9.166

Review 5.  Immunologic aspects of Graves' and Hashimoto's diseases.

Authors:  A Kidd; N Okita; V V Row; R Volpé
Journal:  Metabolism       Date:  1980-01       Impact factor: 8.694

6.  The gas chromatographic determination of atenolol in biological samples.

Authors:  B Scales; P B Copsey
Journal:  J Pharm Pharmacol       Date:  1975-06       Impact factor: 3.765

7.  Inhibition of mitogen-induced lymphocyte transformation by local anesthetics.

Authors:  R M Ferguson; J R Schmidtke; R L Simmons
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

8.  The in vitro effects of propranolol and atenolol on neutrophil motility and post-phagocytic metabolic activity.

Authors:  R Anderson; A J van Rensburg
Journal:  Immunology       Date:  1979-05       Impact factor: 7.397

9.  Atenolol determination by high-performance liquid chromatography and fluorescence detection.

Authors:  Y G Yee; P Rubin; T F Blaschke
Journal:  J Chromatogr       Date:  1979-04-01

10.  Determination of propranolol and six metabolites in human urine by high-pressure liquid chromatography.

Authors:  J F Pritchard; D W Schneck; A H Hayes
Journal:  J Chromatogr       Date:  1979-01-01
View more
  3 in total

1.  Enhancing in vivo effect of propranolol on human lymphocyte function is not due to stereospecific beta-adrenergic blockade.

Authors:  H Mangge; B Pietsch; W Lindner; H Warnkross; G Leb; K Schauenstein
Journal:  Agents Actions       Date:  1993-03

Review 2.  Innovative drug treatments for viral and autoimmune myocarditis.

Authors:  S Anandasabapathy; W H Frishman
Journal:  J Clin Pharmacol       Date:  1998-04       Impact factor: 3.126

3.  Diagnosis and management of viral myocarditis.

Authors:  William H Frishman; Joshua Zeidner; Nauman Naseer
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.